ProCE Banner Activity

Avoiding Common Mistakes in Tardive Dyskinesia Management

Clinical Thought
Tardive dyskinesia can be tricky to identify and manage. Here, Greg Mattingly, MD, describes the common mistakes he observes in TD care and how to avoid them in your clinical practice.

Released: July 13, 2022

Expiration: July 12, 2023

Share

Faculty

Greg W. Mattingly

Greg W. Mattingly, MD

Greg W. Mattingly, MD

Associate Clinical Professor

Department of Psychiatry

Washington University School of Medicine

President

St. Charles Psychiatry Associates

St. Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Neurocrine Biosciences

Faculty Disclosure

Primary Author

Greg W. Mattingly, MD

Greg W. Mattingly, MD

Associate Clinical Professor

Department of Psychiatry

Washington University School of Medicine

President

St. Charles Psychiatry Associates

St. Louis, Missouri

Greg W. Mattingly, MD: speaker: AbbVie, Alkermes, Corium, Eisai, Intracellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Supernus, Takeda, Trispharma; consultant: AbbVie, Acadia, Alkermes, Axsome, Corium, Eisai, Ironshore, Intracellular, Janssen, Lundbeck, Neos, Neurocrine, Noven, Otsuka, Redax, Roche, Rhodes, Sage, Sirona, Sunovion, Supernus, Takeda, Teva, Trispharma; researcher: AbbVie, Acadia, Alkermes, Akili, Axsome, Boehringer, Emalex, Idorsia, Janssen, Karuna, Lumos Labs, Medgenics, NLS-1 Pharma AG, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva.